Click on image to view larger version.

Figure 1 Study protocol. Summary of the 12-week study protocol including double-blind randomization to placebo/mibefradil 50 mg therapy for one week followed by four weeks of placebo/mibefradil 100 mg therapy with cross-over to the alternative therapy after a one-week washout period.